Gabriela Riemekasten - Klinische Immunologie - University of Lübeck

Gabriela Riemekasten - Klinische Immunologie

Early Academic Pursuits

Prof. Dr. med. Gabriela Riemekasten embarked on her academic journey with a comprehensive study of Medicine at the prestigious Charité University Hospital in Berlin, Germany. Her dedication and scholarly acumen culminated in a noteworthy medical thesis, earning her the esteemed "summa cum laude" distinction under the mentorship of Prof. Falk Hiepe in 1991.

Professional Endeavors

Over the years, Dr. Riemekasten's career has been marked by significant milestones. Notably, she attained certification in Immunology from the German Society for Immunology in 2021. Her leadership roles include serving as the Director of the Clinic for Rheumatology and Clinical Immunology at the University of Lübeck since 2015, further solidifying her position as a respected figure in the field.

Contributions and Research Focus

Dr. Riemekasten's contributions to the research landscape are both extensive and impactful. Her habilitation in Rheumatology in 2003 at Charité University Hospital Berlin underscored her commitment to advancing knowledge in the field. Noteworthy research projects include postdoctoral work at the University of California, Los Angeles, and pioneering studies on autoimmune responses in diseases like Lupus nephritis and systemic sclerosis.

Accolades and Recognition

Her professional journey has been adorned with recognition, including board memberships in national and international rheumatology organizations. Notably, she received the Nils-Ilja-Richter Prize of the Deutsche Autoimmunstiftung in 2022, acknowledging her exceptional contributions to autoimmune disease research.

Impact and Influence

Dr. Riemekasten's influence extends beyond her institutional roles. As a mentor and supervisor, she has guided numerous researchers in early career phases, fostering a new generation of experts in the field. Her involvement in international symposiums and committees showcases her commitment to collaborative and impactful research.

Legacy and Future Contributions

The legacy of Prof. Dr. med. Gabriela Riemekasten is imprinted in her numerous publications and patents, reflecting her pioneering work in autoimmune diseases. As a member of executive groups and steering committees, her strategic vision is contributing to the future of precision medicine in chronic inflammation. With an unyielding commitment to mentorship and education, her legacy is poised to shape the future of rheumatology research and clinical practice.

Notable Publications

Vasoregulatory Autoantibodies and Clinical Outcome After Ischemic Stroke-PROSCIS-B 2023, 12(23)

Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach 2023, 9(1), 21

Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome – State of the art: Report of the 2nd international meeting at the Charité Fatigue Center   November 2023, 103452


Gabriela Riemekasten – Klinische Immunologie – Excellence in Innovation-5738

You May Also Like